Glucotrack (GCTK) Return on Equity (2011 - 2025)

Glucotrack has disclosed Return on Equity across 15 years of filings, most recently posting 0.06% for Q4 2025.

• Quarterly Return on Equity fell 7.0% year-over-year to 0.06% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.06% (down 7.0% YoY) and the FY2025 annual result came in at 0.03%, changed 0.0% from the prior year.
• Return on Equity slipped to 0.06% in Q4 2025, from 0.03% in the prior quarter.
• Over five years, Return on Equity peaked at 0.08% in Q2 2024 and troughed at 0.07% in Q1 2023.
• A 5-year average of 0.01% and a median of 0.01% in 2022 frame the typical range for Return on Equity.
• Annual changes were most pronounced in 2024 — Return on Equity rose 10 bps — and 2025, when it decreased 10 bps.
• Tracing GCTK's Return on Equity over 5 years: stood at 0.01% in 2021, then sank by 257 bps to 0.02% in 2022, then jumped by 34 bps to 0.02% in 2023, then soared by 205 bps to 0.02% in 2024, then plunged by 437 bps to 0.06% in 2025.
• Business Quant data shows GCTK's Return on Equity at 0.06% in Q4 2025, 0.03% in Q3 2025, and 0.02% in Q2 2025.